Non-Invasive Monitoring Systems

Non-Invasive Monitoring Systems EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Non-Invasive Monitoring Systems (NIMU) as of Oct 11, 2026 is -53.22. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -53.22 — a change of 0.00% (lower).

EV/EBIT

-53.22

YoY

0.00%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Non-Invasive Monitoring Systems is 2026 -53.22 . EV/EBIT (Enterprise Value to EBIT) of Non-Invasive Monitoring Systems was 2025 -53.22 . It decreases by 0.00% lower compared to the previous year.

The Non-Invasive Monitoring Systems EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2019
-19.09 USD
Jan 1, 2020
-51.60 USD
Jan 1, 2021
-53.89 USD
Jan 1, 2022
-53.55 USD
Jan 1, 2023
-50.38 USD
Jan 1, 2024
-48.11 USD
Jan 1, 2025
-53.22 USD
Jan 1, 2026
-53.22 USD
The Non-Invasive Monitoring Systems EV/EBIT history
YEAREV/EBITYoY
-53.220.00%
-53.22+10.62%
-48.11-4.52%
-50.38-5.92%
-53.55-0.63%
-53.89+4.43%
-51.60+170.30%
-19.09-49.55%
-37.84+31.11%
-28.86+93.90%
-14.89-51.92%
-30.96+13.82%
-27.20+271,931.49%
-0.01—
0.00—
0.00—
0.00—
0.00—
0.00—
0.00—
Access this data via the Eulerpool API

Non-Invasive Monitoring Systems Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Non-Invasive Monitoring Systems's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Non-Invasive Monitoring Systems's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Non-Invasive Monitoring Systems's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Non-Invasive Monitoring Systems grows earnings faster than its peers.

Non-Invasive Monitoring Systems Stock analysis

What does Non-Invasive Monitoring Systems do? Non-Invasive Monitoring Systems Inc (NIMS) has become a major player in the field of medical diagnostics and monitoring in recent years. The company was founded in 2002 and is headquartered in Miami, Florida. Its focus is on developing and marketing innovative non-invasive technologies that enable better patient care. NIMS' business model is based on the development and marketing of products that allow for fast and accurate diagnosis of various medical conditions. These technologies can be used in various clinical areas such as intensive care, oncology, cardiology, and neurology. The company's goal is to improve patient care by making diagnostics and monitoring faster, more accurate, and more effective. NIMS has several divisions that focus on different medical applications. One of these is the gastrointestinal division, which specializes in the diagnosis and monitoring of gastrointestinal disorders. NIMS offers innovative technologies such as magnetic resonance elastography (MRE-MRI), which allows for the measurement of tissue hardness without invasive procedures. This technology is particularly used in the early detection of cancer, as it enables the detection of tissue changes at an early stage. Another important division of NIMS is cardiovascular monitoring, which aims at the early detection and monitoring of heart diseases. The company offers various non-invasive technologies for this purpose, such as wearable devices for measuring blood pressure and heart rate, or ultrasound for measuring blood flow and vascular stiffness. These technologies are intended to improve the monitoring of patients with heart diseases and to detect complications at an early stage. NIMS also offers innovative diagnostic tools for the early detection of cancer, such as the Cancer Screening Index (CSI). The CSI is a biomarker-based test that calculates the probability of developing certain types of cancer. Various factors such as family history, smoking, or age are taken into account in the calculation. The CSI aims to contribute to the early detection of cancer and thus enable better prognosis. In addition to these products, NIMS is also involved in clinical research. The company offers specialized services such as conducting clinical trials or providing expert opinions. These services are intended to promote the development of new non-invasive diagnostic and monitoring technologies and thus improve overall patient care. Overall, NIMS has become a leading company in the field of non-invasive medical diagnostics and monitoring. The company is constantly striving to advance the development of new innovative technologies to improve patient care and minimize the use of invasive procedures. With its various divisions and products, NIMS is able to cover various medical applications and thus appeal to a broad customer base. Non-Invasive Monitoring Systems is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Non-Invasive Monitoring Systems stock

EV/EBIT (Enterprise Value to EBIT) of Non-Invasive Monitoring Systems is -53.22 in 2026.

EV/EBIT (Enterprise Value to EBIT) of Non-Invasive Monitoring Systems changed from -53.22 to -53.22, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Non-Invasive Monitoring Systems since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Non-Invasive Monitoring Systems with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Non-Invasive Monitoring Systems

All Key Metrics — Non-Invasive Monitoring Systems